The results show about 3-fold increase in the frequency of both Th1 and Th17 phenotypes in ex vivo activated CD4+ T-cells obtained from PD patients in comparison with those obtained from HC (Figure 1C). The gene discussed is CD4; the disease is Parkinson disease.